Symbol="TERN"
AssetType="Common Stock"
Name="Terns Pharmaceuticals Inc"
Description="Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of nonalcoholic steatohepatitis (NASH) and other chronic liver diseases. The company is headquartered in Foster City, California."
CIK="1831363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="465910000"
EBITDA="-71942000"
PERatio="None"
PEGRatio="None"
BookValue="5.08"
DividendPerShare="0"
DividendYield="0"
EPS="-1.35"
RevenuePerShareTTM="0.035"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.198"
ReturnOnEquityTTM="-0.312"
RevenueTTM="1000000"
GrossProfitTTM="1000000"
DilutedEPSTTM="-1.35"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="17.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="256.53"
PriceToBookRatio="1.339"
EVToRevenue="60.08"
EVToEBITDA="-1.033"
Beta="-1.06"
num_52WeekHigh="14.04"
num_52WeekLow="1.79"
num_50DayMovingAverage="11.23"
num_200DayMovingAverage="9.08"
SharesOutstanding="56680000"
DividendDate="None"
ExDividendDate="None"
symbol="TERN"
open="8.28"
high="8.50"
low="7.93"
price="8.22"
volume="482932.00"
latest_trading_day="2023-07-07"
previous_close="8.26"
change="-0.04"
change_percent="-0.4843%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="9"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="91"
Volume_recent_avg="634876"
Change_recent_avg="-0.05"
Delta_recent_avg="0.87"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.64"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="91"
Aroon_momentum_negative="9"
image_negative_thumbnail_id_1="1131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_negative_thumbnail_id_2="99"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_neutral_thumbnail_id_1="579"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="650"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_positive_thumbnail_id_2="953"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
